Unknown

Dataset Information

0

A novel bispecific c-MET/PD-1 antibody with therapeutic potential in solid cancer.


ABSTRACT: The bispecific antibody is a novel antibody, which can target two different antigens and mediate specific killing effects by selectively redirecting effector cells to the target cells. Here, we designed and synthesized a bispecific antibody (BsAb) that can bind cellular-mesenchymal to epithelial transition factor (c-MET, overexpressed in several human solid tumor), and programmed death-1 (PD-1, involved in cancer cell immune evasion) with high affinity and specificity. We found that BsAb can induce the degradation of c-MET protein in cancer cells, including MKN45, a gastric cancer cell line, and A549, a lung cancer cell line. BsAb inhibited hepatocyte growth factor (HGF)-mediated proliferation, migration, and antiapoptosis, and downregulated HGF-stimulated phosphorylation of c-MET, protein kinase B (AKT), and extracellular signal-regulated kinase (ERK1/2). BsAb can also rescue T cell activation. Furthermore, xenograft analysis revealed that BsAb markedly inhibits the growth of subcutaneously implanted tumors and chronic inflammation. On the basis of these results, we have identified a potential bispecific drug, which can effectively target c-MET and PD-1 for the treatment of human solid cancers.

SUBMITTER: Sun ZJ 

PROVIDER: S-EPMC5438713 | biostudies-literature | 2017 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

A novel bispecific c-MET/PD-1 antibody with therapeutic potential in solid cancer.

Sun Zu-Jun ZJ   Wu Yi Y   Hou Wei-Hua WH   Wang Yu-Xiong YX   Yuan Qing-Yun QY   Wang Hui-Jie HJ   Yu Min M  

Oncotarget 20170401 17


The bispecific antibody is a novel antibody, which can target two different antigens and mediate specific killing effects by selectively redirecting effector cells to the target cells. Here, we designed and synthesized a bispecific antibody (BsAb) that can bind cellular-mesenchymal to epithelial transition factor (c-MET, overexpressed in several human solid tumor), and programmed death-1 (PD-1, involved in cancer cell immune evasion) with high affinity and specificity. We found that BsAb can ind  ...[more]

Similar Datasets

| S-EPMC7495354 | biostudies-literature
| S-EPMC7987916 | biostudies-literature
| S-EPMC6136863 | biostudies-other
| S-EPMC10254625 | biostudies-literature
| S-EPMC8296967 | biostudies-literature
| S-EPMC7175222 | biostudies-literature
| S-EPMC8393954 | biostudies-literature
| S-EPMC7813985 | biostudies-literature
| S-EPMC8678608 | biostudies-literature
| S-EPMC2975237 | biostudies-literature